Shannon Lentz

Hatch-Waxman PTE For Reissue Patents Should Be Calculated From The Original Patent's Issue Date

USPTO Finds Claims Of Two Of Moderna's MRNA Patents Unpatentable: What's Next In The Vaccine Wars?

The Pendulum Of Fintiv In Motion

Enabling Practitioners: USPTO Issues Guidelines For Assessing Enablement Post-Amgen